Isabel Heidrich

525 total citations
18 papers, 321 citations indexed

About

Isabel Heidrich is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, Isabel Heidrich has authored 18 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Isabel Heidrich's work include Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (6 papers). Isabel Heidrich is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (6 papers). Isabel Heidrich collaborates with scholars based in Germany, Austria and Netherlands. Isabel Heidrich's co-authors include Klaus Pantel, Stefan Werner, Matthias Reeh, Christoffer Gebhardt, Stefan W. Schneider, Antje Andreas, Christian Meß, Kai Bartkowiak, Simon A. Joosse and Sven Peine and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Clinical Chemistry.

In The Last Decade

Isabel Heidrich

16 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Heidrich Germany 8 192 172 128 67 42 18 321
Eirini Biziota Greece 8 147 0.8× 158 0.9× 151 1.2× 76 1.1× 29 0.7× 18 319
Cédric van Marcke Belgium 12 165 0.9× 156 0.9× 124 1.0× 92 1.4× 41 1.0× 34 370
Ji Won Woo South Korea 10 118 0.6× 219 1.3× 82 0.6× 58 0.9× 41 1.0× 18 352
Lars Buschhorn Germany 5 114 0.6× 102 0.6× 105 0.8× 79 1.2× 21 0.5× 11 271
Xiaoyu Pu China 6 182 0.9× 297 1.7× 108 0.8× 101 1.5× 15 0.4× 12 403
Zu-Shun Chen China 7 185 1.0× 165 1.0× 112 0.9× 64 1.0× 15 0.4× 10 356
Morten Lapin Norway 8 299 1.6× 233 1.4× 134 1.0× 121 1.8× 35 0.8× 15 359
Lisanne F. van Dessel Netherlands 8 211 1.1× 116 0.7× 149 1.2× 99 1.5× 39 0.9× 13 319
Wenbo Zheng China 11 196 1.0× 104 0.6× 189 1.5× 47 0.7× 30 0.7× 21 338
Hao Dang Netherlands 10 111 0.6× 148 0.9× 141 1.1× 117 1.7× 31 0.7× 27 330

Countries citing papers authored by Isabel Heidrich

Since Specialization
Citations

This map shows the geographic impact of Isabel Heidrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Heidrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Heidrich more than expected).

Fields of papers citing papers by Isabel Heidrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Heidrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Heidrich. The network helps show where Isabel Heidrich may publish in the future.

Co-authorship network of co-authors of Isabel Heidrich

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Heidrich. A scholar is included among the top collaborators of Isabel Heidrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Heidrich. Isabel Heidrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Heidrich, Isabel, Daniel J. Smit, Rüdiger Greinert, et al.. (2025). Baseline D-dimers as predictive marker of efficacy of cemiplimab treatment in cutaneous squamous cell carcinoma. European Journal of Cancer. 226. 115639–115639.
2.
Heidrich, Isabel, Antje Andreas, Anne Menz, et al.. (2025). In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibition. Journal of Experimental & Clinical Cancer Research. 44(1). 202–202. 2 indexed citations
3.
4.
5.
Heidrich, Isabel, Daniel J. Smit, Michael Weichenthal, et al.. (2024). C‐reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma. Journal of the European Academy of Dermatology and Venereology. 38(8). 1575–1587. 4 indexed citations
6.
Heidrich, Isabel, Daniel J. Smit, Dirk Schadendorf, et al.. (2024). Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy. European Journal of Cancer. 202. 113989–113989. 6 indexed citations
7.
Meß, Christian, Isabel Heidrich, Daniel J. Smit, et al.. (2024). Differential predictive value of tissue‐specific PD‐L1 expression scores in adjuvant immunotherapy of melanoma. Journal of the European Academy of Dermatology and Venereology. 38(10). 2017–2023. 1 indexed citations
8.
Heidrich, Isabel, et al.. (2023). Liquid Biopsy – Ein neues diagnostisches Konzept in der Onkologie. Laryngo-Rhino-Otologie. 103(1). 40–46. 1 indexed citations
9.
Heidrich, Isabel, et al.. (2023). Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors. Cancer and Metastasis Reviews. 42(1). 161–182. 33 indexed citations
10.
Keller, Laura, Christian Meß, Alexander T. Bauer, et al.. (2023). Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 11(5). e006456–e006456. 11 indexed citations
11.
Gebhardt, Christoffer, Laura Keller, Isabel Heidrich, et al.. (2023). Association of ultra-sensitive ctDNA assay to identify actionable variants and response to immune checkpoint inhibitor (ICI) therapy in metastatic melanoma.. Journal of Clinical Oncology. 41(16_suppl). 9562–9562. 1 indexed citations
12.
Heidrich, Isabel & Klaus Pantel. (2022). Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts. EMBO Molecular Medicine. 14(8). e16326–e16326. 6 indexed citations
13.
Heidrich, Isabel, et al.. (2022). Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma. npj Precision Oncology. 6(1). 17–17. 13 indexed citations
14.
Werner, Stefan, Isabel Heidrich, & Klaus Pantel. (2021). Clinical management and biology of tumor dormancy in breast cancer. Seminars in Cancer Biology. 78. 49–62. 22 indexed citations
15.
Bartkowiak, Kai, Isabel Heidrich, Marcel Kwiatkowski, et al.. (2021). Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells. Cancers. 13(3). 563–563. 9 indexed citations
16.
Heidrich, Isabel, et al.. (2021). Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer. Cancers. 13(18). 4500–4500. 19 indexed citations
17.
Bartkowiak, Kai, Isabel Heidrich, Marcel Kwiatkowski, et al.. (2021). Circulating Cellular Communication Network Factor 1 Protein as a Sensitive Liquid Biopsy Marker for Early Detection of Breast Cancer. Clinical Chemistry. 68(2). 344–353. 9 indexed citations
18.
Heidrich, Isabel, et al.. (2020). Liquid biopsies: Potential and challenges. International Journal of Cancer. 148(3). 528–545. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eirini Biziota Breakdown of academic impact, for papers by Cédric van Marcke Breakdown of academic impact, for papers by Ji Won Woo Breakdown of academic impact, for papers by Lars Buschhorn Breakdown of academic impact, for papers by Xiaoyu Pu Breakdown of academic impact, for papers by Zu-Shun Chen Breakdown of academic impact, for papers by Morten Lapin Breakdown of academic impact, for papers by Lisanne F. van Dessel Breakdown of academic impact, for papers by Wenbo Zheng Breakdown of academic impact, for papers by Hao Dang
Rankless by CCL
2026